Lidocaine Patch 5% — Class III drug recall D-0857-2018
Terminated recall by Teva Pharmaceuticals USA, reported 2018-05-30. Failed Stability Specifications
| Recall number | D-0857-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2018-04-30 |
| Classified | 2018-06-11 |
| Reported by FDA | 2018-05-30 |
| Terminated | 2019-01-14 |
| Quantity | 30,382 patches |
| Reason classes | specification failure |
| NDC | 00591-3525, 00591-3525-11, 00591-3525-30 |
| Lot numbers | 1147020, 1147020B |
Product
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0857-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.